| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Advances in diagnosis, classification, pathophysiology, and management of trigeminal neuralgia
|
Bendtsen, Lars
|
|
|
19 |
9 |
p. 784-796
|
article
|
| 2 |
Avicenna: effects of opium on sensation and pain
|
Dadmehr, Majid
|
|
|
19 |
9 |
p. 724a-724
|
article
|
| 3 |
Brain insulin resistance in Alzheimer's disease and related disorders: mechanisms and therapeutic approaches
|
Kellar, Derek
|
|
|
19 |
9 |
p. 758-766
|
article
|
| 4 |
Charlene Gamaldo
|
|
|
|
19 |
9 |
p. 724
|
article
|
| 5 |
Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort study
|
Jacobi, Heike
|
|
|
19 |
9 |
p. 738-747
|
article
|
| 6 |
Correction to Lancet Neurol 2019; 18: 238–47
|
|
|
|
19 |
9 |
p. e8
|
article
|
| 7 |
Correction to Lancet Neurol 2020; 19: 491–501
|
|
|
|
19 |
9 |
p. e8
|
article
|
| 8 |
COVID-19 and selective vulnerability to Parkinson's disease
|
Pavel, Alexandra
|
|
|
19 |
9 |
p. 719
|
article
|
| 9 |
COVID-19 in older people with cognitive impairment in Latin America
|
Ibanez, Agustin
|
|
|
19 |
9 |
p. 719-721
|
article
|
| 10 |
COVID-19 related stroke in young individuals
|
Fifi, Johanna T
|
|
|
19 |
9 |
p. 713-715
|
article
|
| 11 |
Creating a personal music playlist to help treat dementia
|
Ranscombe, Peter
|
|
|
19 |
9 |
p. 726
|
article
|
| 12 |
Latin America takes centre stage in dementia prevention
|
The Lancet Neurology,
|
|
|
19 |
9 |
p. 711
|
article
|
| 13 |
Leopold Auerbach
|
Wincewicz, Andrzej
|
|
|
19 |
9 |
p. 723
|
article
|
| 14 |
Mitchell Elkind—soon to lead the American Heart Association
|
Kirby, Tony
|
|
|
19 |
9 |
p. 722
|
article
|
| 15 |
Neurological associations of COVID-19
|
Ellul, Mark A
|
|
|
19 |
9 |
p. 767-783
|
article
|
| 16 |
Our brains electric
|
Stirrups, Robert
|
|
|
19 |
9 |
p. 725
|
article
|
| 17 |
Reappraisal of an ALS trial: unaccounted procedural risk
|
Turnbull, John
|
|
|
19 |
9 |
p. 717-718
|
article
|
| 18 |
Safety, tolerability, and efficacy of orally administered atogepant for the prevention of episodic migraine in adults: a double-blind, randomised phase 2b/3 trial
|
Goadsby, Peter J
|
|
|
19 |
9 |
p. 727-737
|
article
|
| 19 |
Seeking transpaRINcy for rituximab dosing in NMOSD
|
Clarke, Antonia J
|
|
|
19 |
9 |
p. 716
|
article
|
| 20 |
Seeking transpaRINcy for rituximab dosing in NMOSD – Authors' reply
|
Tahara, Masayuki
|
|
|
19 |
9 |
p. 716-717
|
article
|
| 21 |
Seizure outcome and use of antiepileptic drugs after epilepsy surgery according to histopathological diagnosis: a retrospective multicentre cohort study
|
Lamberink, Herm J
|
|
|
19 |
9 |
p. 748-757
|
article
|
| 22 |
Targeting CGRP in migraine: a matter of choice and dose
|
Al-Hassany, Linda
|
|
|
19 |
9 |
p. 712-713
|
article
|
| 23 |
Thank you to our peer reviewers in 2019
|
Hart, Laura
|
|
|
19 |
9 |
p. 715
|
article
|
Journal description